Analysis of package inserts of orally administered drugs available in the Indian market

Maheshi U. Chhaya

doi:10.18203/2320-6012.ijrms20170145

Authors

Maheshi U. Chhaya Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai Central, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20170145

Keywords:

Drug, Excipients, Package insert, Posology, Schedule D, Shelf Life

Abstract

Background: The package insert of a medication forms an important source of information to the patient while taking a drug. The package insert is expected to contain complete information regarding the drug aiding the patient to obtain additional knowledge regarding the drug.

Methods: 100 package inserts of orally administered drugs were obtained from local chemists and were analysed according to the Sections 6.2 and 6.3 of Schedule D (II), Drugs and Cosmetics Act (1940) and Rules (1945).

Results: The posology and contraindications were mentioned in 98% and 96% of the inserts, respectively, whereas the list of excipients, incompatibilities and shelf life was mentioned in 12%, 19%, 16% of the inserts, respectively.

Conclusions: There is a wide variation in the information available on the package inserts of drugs available in the Indian market. The package inserts should be carefully scrutinized for completeness before the respective drug is marketed.

Metrics

Metrics Loading ...

References

Kumar A. India has just one doctor for every 1,700 people. The New Indian Express, 2013. Available at http://www.newindianexpress.com/ magazine/ India-has-just-one-doctor-for-every-1700-people/ 2013/ 09/ 22/article1792010.ece Accessed 05 May 2016.

Deo M. Doctor population ratio for India - The reality. Indian J Med Res 2013;137(4):632-5.

Sowmya B, Vijayalakshmi, Narayana R. Critical appraisal of patient package inserts in allopathic medicines. J. Chem. Pharm. Res., 2015;7(3).

Food and Drug Administration, HHS. Requirements on content and format of labeling for human prescription drug and biological products. Fed Reg 2006;71:3921-97.

European Commission. Guideline on the Packaging Information of Medicinal Products for Human Use Authorized by the Union, July 2015. Available at ec.europa.eu/ health/ files/ eudralex/ vol-2/2015-07_14_3_packaging.pdf. Accessed 11 May 2016.

Govt. of India, Ministry of Health and Family Welfare. Drug and Cosmetics Rules, 1945. Available at http://cdsco.nic.in/ html/ Drugs andCosmeticAct.pdf. Accessed 11 May 2016.

Kalam A, Anwar S, Fatima A. Drug package inserts in India: Current scenario. Wor J Pha Pharma Scie. 2014;33(44):385-92.

Shivkar Y. Clinical information in drug package inserts in India. J Postgrad Med. 2009;55(2):104-7.

Morris L. Patient Package Inserts: A new tool for patient education. Public Health Reports. 1977;92(5):421-4.

Hermann F, Herxheimer A, Lionel N. Package inserts for prescribed medicines: what minimum information do patients need? Br Med J. 1978;2(6145):1132-5.

Storflor J, Pettersen L, Slørdal L, Spigset O. Drug package inserts--varying information for the same medicines. Tidsskr Nor Laegeforen. 2013;133(9):955-9.